Clinical Trial Update: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease [Phase 3]

View source ↗

Summary

Clinical trial update announcing the completion of a Phase 3 study evaluating istradefylline (KW-6002) for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• istradefylline (istradefylline)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED